FDA IRB Crackdown Garners Praise From Former Chief Counsel Hutt
This article was originally published in The Pink Sheet Daily
Executive Summary
Coast IRB investigation “shook up IRBs,” Hutt says during BIO panel, “which is good.” Former Deputy Commissioner Torti, Penn’s Fitzgerald note dangers of excessive regulation of IRBs.